Dennis, B., White, V., Huggins, M., Kupfer, D. M., Canfield, D. V., & Whinnery, J. E. (2007). Comparison of Amplification Methods to Produce Affymetrix GeneChip Target Material (Report No. DOT/FAA/AM-07/9). United States. Department of Transportation. Federal Aviation Administration. Office of Aviation. Civil Aerospace Medical Institute. https://rosap.ntl.bts.gov/view/dot/58449
Dennis, Burian, Vicky White, Mark Huggins, Doris M. Kupfer, Dennis V. Canfield, and James E. Whinnery. Comparison of Amplification Methods to Produce Affymetrix GeneChip Target Material. Report no. DOT/FAA/AM-07/9. United States. Department of Transportation. Federal Aviation Administration. Office of Aviation. Civil Aerospace Medical Institute, 2007. https://rosap.ntl.bts.gov/view/dot/58449.
Dennis, Burian, et al. Comparison of Amplification Methods to Produce Affymetrix GeneChip Target Material. United States. Department of Transportation. Federal Aviation Administration. Office of Aviation. Civil Aerospace Medical Institute, 2007, Report no. DOT/FAA/AM-07/9, ROSA P. https://rosap.ntl.bts.gov/view/dot/58449.
Whole blood from living subjects is a convenient matrix to use as a source of RNA for microarray experiments with human subjects especially when subject material is collected at a location other than the collaborating site conducting the microarray work. Collection methods for whole blood that include stabilization of the RNA are known but suffer from issues of decreased sensitivity due to the large amount of globin RNA present from reticulocyte lysis. The experiments presented here were designed to test a globin-RNA reduction protocol in conjunction with three different amplification methods. Statistical analysis of the six different protocols, coupled with post-hybridization quality assurance methods, revealed that an amplification protocol that yielded a fragmented biotin-labeled cDNA product resulted in the highest Percent Present calls from the Affymetrix analysis software and the least methodology based variability. Based on these results, this amplification protocol is expected to lead to the greatest sensitivity and accuracy for differential expression testing of the six amplification methods tested.
Dennis, B., White, V., Huggins, M., Kupfer, D. M., Canfield, D. V., & Whinnery, J. E. (2007). Comparison of Amplification Methods to Produce Affymetrix GeneChip Target Material (Report No. DOT/FAA/AM-07/9). United States. Department of Transportation. Federal Aviation Administration. Office of Aviation. Civil Aerospace Medical Institute. https://rosap.ntl.bts.gov/view/dot/58449
Dennis, Burian, Vicky White, Mark Huggins, Doris M. Kupfer, Dennis V. Canfield, and James E. Whinnery. Comparison of Amplification Methods to Produce Affymetrix GeneChip Target Material. Report no. DOT/FAA/AM-07/9. United States. Department of Transportation. Federal Aviation Administration. Office of Aviation. Civil Aerospace Medical Institute, 2007. https://rosap.ntl.bts.gov/view/dot/58449.
Dennis, Burian, et al. Comparison of Amplification Methods to Produce Affymetrix GeneChip Target Material. United States. Department of Transportation. Federal Aviation Administration. Office of Aviation. Civil Aerospace Medical Institute, 2007, Report no. DOT/FAA/AM-07/9, ROSA P. https://rosap.ntl.bts.gov/view/dot/58449.
ROSA P serves as an archival repository of USDOT-published products including scientific
findings, journal articles, guidelines, recommendations, or other information authored or co-authored by
USDOT or funded partners. As a repository, ROSA P retains documents in their original published format to
ensure public access to scientific information.
Links with this icon indicate that you are leaving a Bureau of Transportation
Statistics (BTS)/National Transportation Library (NTL)
Web-based service.
Thank you for visiting.
You are about to access a non-government link outside of
the U.S. Department of Transportation's National
Transportation Library.
Please note: While links to Web sites outside of DOT are
offered for your convenience, when you exit DOT Web sites,
Federal privacy policy and Section 508 of the Rehabilitation
Act (accessibility requirements) no longer apply. In
addition, DOT does not attest to the accuracy, relevance,
timeliness or completeness of information provided by linked
sites. Linking to a Web site does not constitute an
endorsement by DOT of the sponsors of the site or the
products presented on the site. For more information, please
view DOT's Web site linking policy.
To get back to the page you were previously viewing, click
your Cancel button.